health_en

Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets

Terran to advance the development of two of Sanofi’s Phase 3 CNS therapeutics Transaction includes worldwide exclusive rights for development and commercialization in all fields of use Terran Biosciences, Inc. (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Sanofi S.A. […]

thaipr.net

22 เม.ย. 65

Translumina launches VIVO ISAR, its Dual-Drug Polymer-free Coated Stent (DDCS) in International markets

Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company’s global growth journey  Translumina, a global developer and manufacturer of innovative cardiovascular medical devices used in interventional cardiology, announces the launch of VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in various International markets including Europe.  As an organization,…

thaipr.net

19 เม.ย. 65

Cambrex Completes Large-Scale US API Expansion

Cambrex announced today the completion of a $50 million expansion of its large-scale active pharmaceutical ingredient (API) manufacturing capabilities at its Charles City, Iowa facility. The startup of the new manufacturing space is the culmination of a two-year project, originally announced in 2020, to increase the capacity of Cambrex’s flagship API facility by 30%. The […]

thaipr.net

18 เม.ย. 65

Illumina Singapore Jumps the Ranks to Earn Two Significant Spots in Singapore’s Best Employers Award

The Annual Singapore’s Best Employers survey is sponsored by The Straits Times and marketing firm, Statista. Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) was honoured today to be ranked #17 overall and #1 in Healthcare Equipment & Services in Singapore’s Best Employers Award. The Singapore Employer of Choice is a large scale and comprehensive […]

thaipr.net

18 เม.ย. 65

TauRx’s late-stage clinical trial reaches new milestone

– Significant milestone in the only late-stage clinical trial targeting tau pathology of Alzheimer’s – TauRx on track to announce top line results in May – Trial aims to confirm efficacy of first tau-based treatment for Alzheimer’s TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer’s Disease (AD) research, has announced that the last patient has completed treatment […]

thaipr.net

18 เม.ย. 65

Esaote S.p.A. turns 40 and is confirmed as a leading player in the world market for diagnostic imaging with ultrasound systems, magnetic resonance imaging and information technology for healthcare

Esaote S.p.A., a leading biomedical company in the diagnostic imaging sector – in the fields of ultrasound, magnetic resonance and Information Technology for health – celebrates forty years of activity. Born from scratch in 1982, the Italian company – with headquarters in Genoa and present today in 100 countries around the world – has immediately carved […]

thaipr.net

18 เม.ย. 65

International Team Led by BGI Completes First Whole-Body Cell Atlas of a Non-Human Primate

The research will provide insights into the development of potential treatments for neurological diseases and obesity, among other human conditions. In a breakthrough that could lead to scientific advancement in the treatment of human diseases, researchers from BGI-Research, together with scientific research teams from China, Germany, Italy, Singapore, Spain, Sweden and the UK, today published […]

thaipr.net

18 เม.ย. 65

DEBIOPHARM ANNOUNCES ONCOLOGY RESEARCH ADVANCEMENTS AT AACR 2022 FOR NOVEL CANCER COMPOUNDS AND DRUG DELIVERY TECHNOLOGIES

Pre-clinical & clinical exploratory poster presentations to highlight oncology results withDebio 0123, xevinapant, and Multilink™ technology for antibody drug conjugates Debiopharm, (www.debiopharm.com/debiopharm-international/) an oncology and infectious disease focused biopharmaceutical company based in Switzerland, today announced data releases on 3 investigational products including Debio 0123 (Selective WEE1 inhibitor), clinical…

thaipr.net

12 เม.ย. 65

Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio’s preclinical advances in multiple therapeutic areas Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that it closed an oversubscribed fundraising round to support the next stage of […]

thaipr.net

12 เม.ย. 65
1 … 74 75 76 77 78 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.